DekaBank Deutsche Girozentrale’s Adaptive Biotechnologies ADPT Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio ADPT Stock Details ADPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-59,600	Closed	-$493K	–	1249
2023 Q1	$493K	Hold	59,600	–	–	﹤0.01%	1011
2022 Q4	$444K	Hold	59,600	–	–	﹤0.01%	1063
2022 Q3	$400K	Hold	59,600	–	–	﹤0.01%	1086
2022 Q2	$480K	Hold	59,600	–	–	﹤0.01%	1026
2022 Q1	$827K	Buy	59,600 +5,400	+10%	+$84.9K	﹤0.01%	950
2021 Q4	$1.41M	Buy	54,200 +11,200	+26%	+$343K	﹤0.01%	858
2021 Q3	$1.4M	Hold	43,000	–	–	﹤0.01%	817
2021 Q2	$1.79M	Hold	43,000	–	–	0.01%	749
2021 Q1	$1.63M	Hold	43,000	–	–	0.01%	758
2020 Q4	$2.54M	Buy	43,000 +2,900	+7%	+$150K	0.01%	613
2020 Q3	$1.9M	Buy	+40,100	New	+$1.69M	0.01%	597

Other funds holding ADPT

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MCMC

Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

AAP

Aristotle Atlantic Partners Sarasota, Florida $2.14B AUM 37.01% 1-Year Est. Return

BWLSA

Blue Water Life Science Advisors Larkspur, California $125M AUM 91.82% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

DekaBank Deutsche Girozentrale's ADPT Position: Q2 2023 in Review

DekaBank Deutsche Girozentrale sold out of Adaptive Biotechnologies (ADPT) in Q2 2023, closing a stake of 59,600 shares — an estimated $493K sold.

DekaBank Deutsche Girozentrale first reported a position in ADPT in Q3 2020 and held it in 11 quarters. The position peaked at $2.54M in Q4 2020. 210 funds tracked by Wall St. Rank hold ADPT as of Q2 2023.

DekaBank Deutsche Girozentrale reported no remaining Adaptive Biotechnologies position as of Q2 2023 after selling out during the quarter.
DekaBank Deutsche Girozentrale sold 59,600 Adaptive Biotechnologies shares in Q2 2023, an estimated $493K.
DekaBank Deutsche Girozentrale first reported a position in Adaptive Biotechnologies in Q3 2020 and held it in 11 quarters.
DekaBank Deutsche Girozentrale's Adaptive Biotechnologies position peaked at $2.54M in Q4 2020.
210 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2023.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q2 2023, filed 25 Jul 2023.